Methamphetamin dependency. Psychostimulants with abuse potential
Conditions
Interventions
Intervention 1: Standard group give Haloperidol 1mg during 1week, than 1mg/bid during 3 week. Intervention 2: Intervention group give Opium tincture 14cc/day during 2week, than is low 1cc every 4 days
Treatment - Drugs
Standard group give Haloperidol 1mg during 1week, than 1mg/bid during 3 week.
Intervention group give Opium tincture 14cc/day during 2week, than is low 1cc every 4 days.
Sponsors
Vice Chancellor for Research, University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Dependence on methamphetamine (more than 10 times the regular use of methamphetamine or 10 days); Urine tests positive for methamphetamine; Age 18-65 years; Independence and no use of drugs or other addictive drugs at the time of presentation; Complete the consent form; To track patient; Exclusion criteria: Unwillingness person to continue treatment; Patient self-medication or participate in another study; Other addictive drugs or alcohol or drug use during the study period; Non-compliance with medication orders during the study; Coming out of treatment (imprisonment, death, ...); Any behavior that resulted in dismissal laws rehab clinic patient; There are other mental disorders that require treatment or the risk of suicide; Significant diseases of the Thyroid, Kidney, Liver, Gastrointestinal or Cardiovascular; History of diabetes or Heart attack, Seizures, Glaucoma, Tick, Tardive dyskinesia; Female without adequate contraception pregnancy or lactation; Tincture of opium abusers; A history of allergy to Haloperidol; Simultaneous treatment with antipsychotics or mood stabilizers or CYP 2D6 inhibitors Contains: Amiodarone, Bupropion, Celecoxib, Cimetidine, Chlorpromazine, Clomipramine, Fluoxetine, Haloperidol, Methadone, Moclobemide, Paroxetine, Quinidine, Ritonavir, Sertraline, Terbinafine and Thioridazine; So dangerous side effects of medications or the patient is intolerable.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep condition improve. Timepoint: Befor and during and after invetervention. Method of measurement: Beck questionnaire.;Psychotic reaction. Timepoint: Befor and during and after invetervention. Method of measurement: Beck questionnaire and Psychological exam.;Craving. Timepoint: Befor and during and after invetervention. Method of measurement: Psychological exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. mohammad fazli
Arak University of Medical Sciences
Outcome results
None listed